Walleye Capital LLC Deciphera Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $507,932 - $649,316	-37,403 Reduced 11.28%	294,229 $4.63 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $3.35 Million - $5.49 Million	331,632 New	331,632 $5.35 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $239,726 - $391,733	19,364 New	19,364 $358,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $793,931 - $1.28 Million	-115,565 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$7.7 - $37.13 $844,489 - $4.07 Million	109,674 Added 1861.72%	115,565 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $155,875 - $218,850	5,891 New	5,891 $200,000

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.